Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/1998
10/08/1998WO1998043963A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998WO1998043945A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
10/08/1998WO1998043942A1 Novel compounds, their use and preparation
10/08/1998WO1998043665A1 Preventive and/or therapeutic agent for kidney diseases
10/08/1998WO1998043645A1 Inhibitors for the formation of glycosylated protein denaturation products
10/08/1998WO1998043555A1 Intravesical drug delivery system
10/08/1998WO1998043493A1 Pet food composition
10/08/1998CA2285591A1 Intravesical drug delivery system
10/08/1998CA2285372A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
10/08/1998CA2283799A1 Novel human serine carboxypeptidase
10/08/1998CA2253929A1 Preventive and/or therapeutic agent for kidney diseases
10/07/1998EP0869178A1 SAF-3, Sialoadhesin family member-3
10/07/1998EP0869132A1 "Steroid compounds having contraceptive and anti-osteoporosis activity"
10/07/1998EP0869131A1 5-halo-5-deoxy sorbopyranose compounds
10/07/1998EP0869116A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent as well as medicaments containing them
10/07/1998EP0868180A1 Endothelin receptor antagonists
10/07/1998EP0868178A1 Antagonists of gonadotropin releasing hormone
10/07/1998CN1195340A Inhibitors of farnesyl-protein transferase
10/07/1998CN1195295A Method and use of connective tissue growth factor as revellent
10/07/1998CN1195291A Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
10/07/1998CN1195290A Use of CGMP-phosphodiesterase inhibitors to treat impotence
10/07/1998CN1194976A Ortho-substituted benzoylguanidines, process for their preparation, their use as medicament, and medicament comprising them
10/07/1998CN1194862A Medical liquid for invigorating kidney Yang
10/07/1998CN1040105C Process for preparing aminoketone derivatives
10/06/1998US5817683 Naphthoic derivative; hypotensive agent
10/06/1998US5817674 Antiotensin ii receptor antagonists
10/06/1998US5817649 Administering reductase inhibitor and an androgen receptor antagonist
10/06/1998US5817481 Medical diagnosis; detecting diseases related to mutants in nucleic acid sequences and altered concentration of polypeptides
10/04/1998CA2233797A1 Pharmaceutical product for application to uterus mucosa
10/02/1998CA2233787A1 Sialoadhesin family member-3
10/01/1998WO1998042738A1 87 human secreted proteins
10/01/1998CA2284550A1 87 human secreted proteins
10/01/1998CA2232461A1 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
09/1998
09/30/1998EP0866691A1 Sublingual and buccal administration of selegiline
09/30/1998EP0866656A1 Inhibition of tumor necrosis factor alpha
09/30/1998EP0736033B1 Novel therapeutic carbohydrate blends useful for aiding premenstrual syndrome
09/30/1998EP0526544B1 Therapeutic uses of actin-binding compounds
09/30/1998CN1194158A Traditional Chinese medicine capsule for eliminating indurated goiter
09/29/1998US5814654 Treatment of hypertension, arrhythmia, angina pectoris, cardiac hypertrophy, diabetes mellitus, organ disorders associated with ischemia, cerebro-ischemic disorders, cell proliferation, endothelial cell injury
09/29/1998US5814630 Quinazoline compounds
09/29/1998CA2140781C Pharmocologically active .alpha.-¬tertiary-aminomethyl|- benzenemethanol derivatives
09/24/1998WO1998041562A1 Non-antigenic branched polymer conjugates
09/24/1998WO1998041538A2 Novel human cytokine/steroid receptor protein
09/24/1998WO1998041227A1 Hgf for treating acute renal failure
09/24/1998CA2284108A1 Novel human cytokine/steroid receptor protein
09/23/1998EP0865428A1 Vitamin d analogues
09/23/1998EP0865426A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds
09/23/1998EP0865293A1 Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
09/23/1998EP0865280A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
09/23/1998EP0700383B1 Novel 1-phenylalkanone 5-ht 4? receptor ligands
09/23/1998CN1193961A Substituted benzylaminopiperidine compounds
09/23/1998CN1193623A Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them
09/23/1998CN1039908C Tricyclic diazepine vasopressin antagonists
09/22/1998US5811562 Pharmceutical compositions for the treatment of osteoporosis, wound healing, transplant rejection, rheumatoid arthritis
09/22/1998US5811553 Quinoline derivatives(2)
09/22/1998US5811549 Process of preparing imidazole compounds
09/22/1998US5811535 Human cartilege gp39-like gene
09/22/1998US5811451 Antiinflammatory agents; infections; osteoporosis; autoimmune diseases; human and veterinary medicine; cattle, dogs, horses; gastrointestinal and respiratory dsystem disorders; glandular disorders
09/22/1998US5811445 Angiotensin ii inhibitors
09/22/1998US5811444 Compositions for reducing abnormal stimulation of endothelin receptors and novel compounds
09/22/1998US5811388 Delivery of drugs to the lower GI tract
09/22/1998US5811126 Mixtures of alginates, water-swellable macromolecules, edible hydrocarbon derivatives, divalent metal salts to crosslink the alginates and therapeutically active materials
09/22/1998US5811097 Decreasing growth of tumor cells by administering blocking agent which binds to extracellular domain of cytotoxic t-lymphocyte-associated molecule and inhibits signaling
09/22/1998CA2093221C N-sulfonylindoline derivatives carrying an amide functional group, their preparation, and the pharmaceutical compositions in which they are present
09/17/1998WO1998040738A1 Prostate specific antigen substrates
09/17/1998WO1998040384A1 1,5-dihydro-pyrazolo[3,4-d]-pyrimidinone derivatives
09/17/1998WO1998040079A1 Serine proteinase inhibitory activity by hydrophobic tetracycline
09/17/1998WO1998030683A3 Nuclear transfer with differentiated fetal and adult donor cells
09/17/1998WO1998024905A3 Secreted proteins and polynucleotides encoding them
09/17/1998DE19709877A1 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate 1,5-dihydro-pyrazolo [3,4-d] -pyrimidinone derivatives
09/17/1998CA2284137A1 Prostate specific antigen substrates
09/17/1998CA2283211A1 1,5-dihydro-pyrazolo[3,4-d]-pyrimidinone derivatives
09/16/1998EP0864087A1 Combinatorial dihydrobenzopyran library
09/16/1998EP0863896A1 Novel imidazole derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists
09/16/1998EP0863875A1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
09/16/1998EP0728128B1 Substituted phenyl compounds
09/16/1998CN1193274A Calcium-ion channel antagonists
09/16/1998CN1192920A Medicine prepared from saliva of duck, dog and wolf for treating lithous diseases and preparing method therefor
09/15/1998US5808065 Pyridazinone derivatives and processes for preparing the same
09/15/1998US5807878 Tetrasubstituted imidazoles
09/15/1998US5807862 Therapeutic compounds containing pyrimidinyl moieties
09/15/1998US5807824 C5A receptor antagonists having substantially no agonist activity
09/15/1998US5807818 Therapeutic uses of bactericidal/permeability increasing protein (BPI) protein products
09/11/1998WO1998039466A2 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
09/11/1998WO1998039329A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/11/1998WO1998039292A1 20-epi-22(r)-lower alkyl-substituted vitamin d derivatives and calcium metabolism improving agents containing the same as the active ingredient
09/11/1998WO1998038859A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
09/11/1998CA2285405A1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/11/1998CA2283275A1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
09/11/1998CA2283272A1 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
09/11/1998CA2283145A1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/11/1998CA2282399A1 Thioaryl sulfonamide hydroxamic acid compounds
09/11/1998CA2282318A1 N-hydroxy 4-sulfonyl butanamide compounds
09/09/1998EP0863208A2 Histidine Kinase polypeptides, polynucleotides encluding the same and use thereof
09/09/1998EP0863207A1 RNA dependent amidotransferase A from Staphylococcus Aureus
09/09/1998EP0862576A1 6-0-methyl erythromycin d and process for making
09/09/1998EP0862567A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists
09/09/1998EP0862559A1 Novel fluorinated or hydroxylated phenylimidazolidines having anti-androgenic activity, method for preparing same, resulting intermediates, and pharmaceutical compositions
09/09/1998EP0862435A1 Inhibitors of farnesyl-protein transferase
09/09/1998EP0715627B1 Indole derivatives as thromboxane a2 antagonists
1 ... 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 ... 562